We are available 24/7


Non-Hodgkin's lymphoma has a new name - ‘Roundup cancer’

A lot of people have come forward claiming that they have developed debilitating diseases after using Roundup and other glyphosate-based herbicides. We are here to help them and stand by them when they seek justice.

Non-Hodgkin's Lymphoma is commonly referred to as "Roundup cancer" after research has proven that glyphosate, an active ingredient of Monsanto's Roundup, can cause this type of cancer.

Dr. Charles William Jameson, Ph.D., a toxicology expert and one of the scientists involved in glyphosate research undertaken by the International Agency for Research on Cancer, presented testimony at the San Francisco Federal Court on March 7, 2018.

He made it clear that oxidative stress from glyphosate-based herbicides causes non-Hodgkin's Lymphoma and that it was credible information. He also mentioned that the glyphosate levels to which farmworkers get exposed while using the herbicide are enough to cause non-Hodgkin's Lymphoma.

Roundup is more toxic than glyphosate alone

With the introduction of genetically engineered glyphosate-resistant crops in 1974, the use of this chemical has increased exponentially, and it is quite alarming to know that as much as 300 million pounds of glyphosate-based herbicides are used in U.S. farmlands each year.

Over the last three decades, the number of reported cases of non-Hodgkin's lymphoma has been increasing, and Roundup weed killer is the major contributor to the rise in these cases. Around 5000 individuals, including farmers and people working in the agriculture field, have filed lawsuits against Monsanto, claiming that they have been diagnosed with non-Hodgkin's Lymphoma as a result of occupational exposure to Roundup.

Recently, the tests conducted by the U.S. National Toxicology Program have revealed that the use of Roundup formula is far more toxic than when glyphosate is used alone. According to this study, Roundup alters the viability of human cells significantly by disrupting the functions of the cell membrane, in other words, Roundup can kill human cells.

The pilot phase results of the global glyphosate study conducted at the Ramazzini Institute in Italy ascertains the carcinogenicity of glyphosate and revealed the genotoxic effects of daily ingestion of glyphosate.

Diagnosis of non-Hodgkin's lymphoma

Non-Hodgkin's lymphoma is a type of cancer that forms in the white blood cells-B-lymphocytes, T-lymphocytes, and natural killer cells. About 80-90% of cases are found to be B-cell lymphomas, 15-20% of cases are T-cell lymphomas, and natural killer lymphomas are quite rare.

These types of tumors develop as a result of chromosomal translocation, chronic inflammation, immunodeficiency conditions, infections, and environmental factors.

Paying attention to the signs and symptoms that are most common in lymphoma is the simplest way to detect non-Hodgkin's lymphoma at an early stage. Common signs and symptoms of non-Hodgkin's lymphoma may include:

  • itching of the skin that doesn't go away
  • enlargement of one or more of the lymph nodes, which causes a non-painful lump under the skin
  • an increased risk of infections

Other symptoms such as fever, chills, fatigue, weight loss, night sweats, abdominal pain/swelling, cough, difficulty breathing, chest pain, headache, and double vision may occur and get worse instead of getting better with time. The appearance of these signs should prompt a medical check-up to find out the exact cause of these symptoms.

Often, a biopsy of the swollen lymph node will be recommended to confirm non-Hodgkin's lymphoma. Other tests that may be performed, which include lab tests on biopsy samples and imaging tests (X-rays, CT scan, MRI scan, ultrasound, bone scan, and positron emission tomography scan). Blood and urine tests may be done to rule out an infection.

Treatment of non-Hodgkin's lymphoma

A multidisciplinary team of doctors, including a medical oncologist or hematologist, radiation oncologist, and bone marrow transplant doctor, works together to ensure a successful outcome. The treatment plan is developed based on the factors such as:

  • the patient's age
  • general health
  • extent and the subtype of non-Hodgkin's Lymphoma

In most cases, chemotherapy alone or in a combination of immunotherapy or radiation therapy will be provided. Chemotherapy involves the administration of anti-cancer drugs into a vein or orally. Immunotherapy employs monoclonal antibodies that have been designed to attack specific antigen targets on the surface of lymphocytes.

Radiation therapy helps kill cancer cells with a focused beam of high-energy X-rays. Targeted drugs are newer treatment methods that have fewer side effects. Surgery is performed only in a few conditions, usually to obtain a biopsy sample and classify the lymphoma.

Non-Hodgkin's lymphoma may sometimes remain obscure until it reaches advanced stages. It may prove to be fatal if diagnosed at later stages. Therefore, it is better we reduce exposure to known carcinogens and risk factors.

Support for patients diagnosed with non-Hodgkin's lymphoma after using Roundup

Victims who have been exposed to the hazardous ingredients in Roundup's formulation may receive payments for medical expenses related to treating blood cancer, pain and suffering, and loss of earnings.

Atraxia Law helps victims who have been diagnosed with lymphatic cancer like non-Hodgkin's lymphoma after using Roundup. So gather all the necessary documents and contact us today.